Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Ganoderma lucidum spore oil (GLSO) is a lipid extract from broken-walled Reishi mushroom spores obtained via supercritical CO₂ extraction, containing triterpenes, fatty acids, and sterols. These triterpenes induce cancer cell apoptosis by activating caspase-3 and caspase-9 pathways while modulating immune function through enhanced NK cell cytotoxicity and macrophage activity.
Reported Benefits (Provisional)
Origin & History
Ganoderma lucidum spore oil is extracted from the spores of the revered Reishi mushroom, a fungus native to East Asia and widely cultivated for medicinal use. This premium oil is obtained through advanced CO₂ extraction or cold-pressing methods to preserve its high concentration of triterpenes and other bioactives. Historically reserved for royalty in traditional Chinese medicine, it is now globally recognized for its potent therapeutic potential.
Research Narrative (Provisional)
Studies confirm Ganoderma lucidum spore oil's immune-modulatory effects, including enhanced T-cell and macrophage activity. Its anti-inflammatory properties are shown via downregulation of NF-κB and COX-2 pathways, while research validates its antioxidant action through increased SOD and glutathione expression.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Triterpenes (ganoderic acids, lucidenic acids) - Polysaccharides (Beta-glucans) - Fatty Acids - Adenosine - Antioxidants
Reported Mechanism (Provisional)
GLSO's triterpenes activate apoptotic pathways in cancer cells by triggering caspase-3 and caspase-9 enzymes, as demonstrated in breast cancer models. The oil enhances immune surveillance by boosting natural killer (NK) cell cytotoxicity and macrophage phagocytosis at doses of 800 mg/kg in animal studies. Antioxidant effects occur through upregulation of superoxide dismutase and catalase while reducing malondialdehyde levels and downregulating inflammatory NF-κB and COX-2 pathways.
Clinical Narrative (Provisional)
Current evidence is limited to preclinical studies, with no published randomized controlled trials in humans available. In vitro studies show GLSO inhibits proliferation of multiple cancer cell lines including HL-60 leukemia, K562 chronic myeloid leukemia, SGC7901 gastric carcinoma, and MDA-MB breast cancer cells. Animal studies demonstrate significant improvements in immune markers, including increased serum half-hemolytic values (HC50, p<0.01) and enhanced neutrophil activity (p<0.05) in zebrafish models. The lack of human clinical data represents a significant evidence gap for therapeutic applications.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.